{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T19:11:21Z","timestamp":1779390681118,"version":"3.53.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,21]]},"DOI":"10.7759\/cureus.109376","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T18:10:13Z","timestamp":1779387013000},"source":"Crossref","is-referenced-by-count":0,"title":["Advanced and More Symptomatic B-Cell Non-Hodgkin Lymphoma at Diagnosis After COVID-19 Disruptions in a Romanian Tertiary Center"],"prefix":"10.7759","author":[{"given":"Paul C","family":"Toboltoc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela","family":"Vekony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagiu","family":"Ioana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02705-8","article-title":"B-cell non-Hodgkin lymphomas","volume":"403","author":"Silkenstedt E","year":"2024","unstructured":"Silkenstedt E, Salles G, Campo E, Dreyling M. B-cell non-Hodgkin lymphomas. Lancet. 2024, 403:1791-807. 10.1016\/S0140-6736(23)02705-8","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson BD","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014, 32:3059-68. 10.1200\/JCO.2013.54.8800","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v91i1.9397","article-title":"WHO declares COVID-19 a pandemic","volume":"91","author":"Cucinotta D","year":"2020","unstructured":"Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020, 91:157-60. 10.23750\/abm.v91i1.9397","journal-title":"Acta Biomed"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.18683\/germs.2020.1198","article-title":"SARS-CoV-2 in Romania - analysis of the first confirmed case and evolution of the pandemic in Romania in the first three months","volume":"10","author":"Streinu-Cercel A","year":"2020","unstructured":"Streinu-Cercel A, Apostolescu C, S\u0103ndulescu O, et al.. SARS-CoV-2 in Romania - analysis of the first confirmed case and evolution of the pandemic in Romania in the first three months. Germs. 2020, 10:132-4. 10.18683\/germs.2020.1198","journal-title":"Germs"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00344","article-title":"The successes and failures of the initial COVID-19 pandemic response in Romania","volume":"8","author":"Dascalu S","year":"2020","unstructured":"Dascalu S. The successes and failures of the initial COVID-19 pandemic response in Romania. Front Public Health. 2020, 8:344. 10.3389\/fpubh.2020.00344","journal-title":"Front Public Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30388-0","article-title":"The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study","volume":"21","author":"Maringe C","year":"2020","unstructured":"Maringe C, Spicer J, Morris M, et al.. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020, 21:1023-34. 10.1016\/S1470-2045(20)30388-0","journal-title":"Lancet Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100197","article-title":"Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis","volume":"6","author":"Peacock HM","year":"2021","unstructured":"Peacock HM, Tambuyzer T, Verdoodt F, et al.. Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis. ESMO Open. 2021, 6:100197. 10.1016\/j.esmoop.2021.100197","journal-title":"ESMO Open"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-022-00946-6","article-title":"Decrease of cancer diagnosis during COVID-19 pandemic: a systematic review and meta-analysis","volume":"38","author":"Angelini M","year":"2023","unstructured":"Angelini M, Teglia F, Astolfi L, Casolari G, Boffetta P. Decrease of cancer diagnosis during COVID-19 pandemic: a systematic review and meta-analysis. Eur J Epidemiol. 2023, 38:31-8. 10.1007\/s10654-022-00946-6","journal-title":"Eur J Epidemiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.32363","article-title":"New cancer diagnoses before and during the COVID-19 pandemic","volume":"6","author":"Decker KM","year":"2023","unstructured":"Decker KM, Feely A, Bucher O, et al.. New cancer diagnoses before and during the COVID-19 pandemic. JAMA Netw Open. 2023, 6:e2332363. 10.1001\/jamanetworkopen.2023.32363","journal-title":"JAMA Netw Open"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00293-0","article-title":"Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment","volume":"24","author":"Han X","year":"2023","unstructured":"Han X, Yang NN, Nogueira L, et al.. Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment. Lancet Oncol. 2023, 24:855-67. 10.1016\/S1470-2045(23)00293-0","journal-title":"Lancet Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.221512","article-title":"Impact of the COVID-19 pandemic on cancer diagnoses, stage and survival in Alberta","volume":"195","author":"Heer E","year":"2023","unstructured":"Heer E, Ruan Y, Boyne DJ, et al.. Impact of the COVID-19 pandemic on cancer diagnoses, stage and survival in Alberta. CMAJ. 2023, 195:E804-12. 10.1503\/cmaj.221512","journal-title":"CMAJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckab214","article-title":"Impact of the first wave of the COVID-19 pandemic on cancer registration and cancer care: a European survey","volume":"32","author":"Neam\u0163iu L","year":"2022","unstructured":"Neam\u0163iu L, Martos C, Giusti F, et al.. Impact of the first wave of the COVID-19 pandemic on cancer registration and cancer care: a European survey. Eur J Public Health. 2022, 32:311-5. 10.1093\/eurpub\/ckab214","journal-title":"Eur J Public Health"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2340\/1651-226X.2024.35238","article-title":"Impact of the COVID-19 pandemic on lymphoma incidence and short-term survival\u2009- a Swedish Lymphoma Register Study","volume":"63","author":"Ekberg S","year":"2024","unstructured":"Ekberg S, Molin D, Pahnke S, Bergstr\u00f6m F, Br\u00e5nvall E, Smedby KE, W\u00e4sterlid T. Impact of the COVID-19 pandemic on lymphoma incidence and short-term survival\u2009- a Swedish Lymphoma Register Study. Acta Oncol. 2024, 63:164-8. 10.2340\/1651-226X.2024.35238","journal-title":"Acta Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2022.100913","article-title":"Diagnosis and management of classical Hodgkin lymphoma during the COVID-19 pandemic","volume":"46","author":"K\u00fc\u00e7\u00fckyurt S","year":"2022","unstructured":"K\u00fc\u00e7\u00fckyurt S, \u015eahin K, Y\u0131lmaz U, et al.. Diagnosis and management of classical Hodgkin lymphoma during the COVID-19 pandemic. Curr Probl Cancer. 2022, 46:100913. 10.1016\/j.currproblcancer.2022.100913","journal-title":"Curr Probl Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4087","article-title":"Mortality due to cancer treatment delay: systematic review and meta-analysis","volume":"371","author":"Hanna TP","year":"2020","unstructured":"Hanna TP, King WD, Thibodeau S, et al.. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. 2020, 371:m4087. 10.1136\/bmj.m4087","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0000000000000686","article-title":"The impact of the coronavirus disease 2019 pandemic on the diagnosis and treatment of cancer in Northern Portugal","volume":"31","author":"Morais S","year":"2022","unstructured":"Morais S, Antunes L, Rodrigues J, Fontes F, Bento MJ, Lunet N. The impact of the coronavirus disease 2019 pandemic on the diagnosis and treatment of cancer in Northern Portugal. Eur J Cancer Prev. 2022, 31:204-14. 10.1097\/CEJ.0000000000000686","journal-title":"Eur J Cancer Prev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp19X701861","article-title":"Missed opportunities for diagnosing brain tumours in primary care: a qualitative study of patient experiences","volume":"69","author":"Walter FM","year":"2019","unstructured":"Walter FM, Penfold C, Joannides A, et al.. Missed opportunities for diagnosing brain tumours in primary care: a qualitative study of patient experiences. Br J Gen Pract. 2019, 69:e224-35. 10.3399\/bjgp19X701861","journal-title":"Br J Gen Pract"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17710","article-title":"A cautionary tale of the use of lenalidomide and dexamethasone for relapsed\/refractory immunoglobulin light chain (AL) amyloidosis","volume":"195","author":"Prince HM","year":"2021","unstructured":"Prince HM. A cautionary tale of the use of lenalidomide and dexamethasone for relapsed\/refractory immunoglobulin light chain (AL) amyloidosis. Br J Haematol. 2021, 195:160-1. 10.1111\/bjh.17710","journal-title":"Br J Haematol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2111","article-title":"Screening of MSI detection loci and their heterogeneity in East Asian colorectal cancer patients","volume":"8","author":"Bai W","year":"2019","unstructured":"Bai W, Ma J, Liu Y, et al.. Screening of MSI detection loci and their heterogeneity in East Asian colorectal cancer patients. Cancer Med. 2019, 8:2157-66. 10.1002\/cam4.2111","journal-title":"Cancer Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-0950-3","article-title":"Total burden of disease in cancer patients at diagnosis-a Danish nationwide study of multimorbidity and redeemed medication","volume":"123","author":"Loeppenthin K","year":"2020","unstructured":"Loeppenthin K, Dalton SO, Johansen C, et al.. Total burden of disease in cancer patients at diagnosis-a Danish nationwide study of multimorbidity and redeemed medication. Br J Cancer. 2020, 123:1033-40. 10.1038\/s41416-020-0950-3","journal-title":"Br J Cancer"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1080\/10428190802124281","article-title":"Delays in referral and diagnosis for chronic hematologic malignancies: a literature review","volume":"49","author":"Abel GA","year":"2008","unstructured":"Abel GA, Friese CR, Magazu LS, Richardson LC, Fernandez ME, De Zengotita JJ, Earle CC. Delays in referral and diagnosis for chronic hematologic malignancies: a literature review. Leuk Lymphoma. 2008, 49:1352-9. 10.1080\/10428190802124281","journal-title":"Leuk Lymphoma"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2014(05)12","article-title":"Time-to-treatment of diffuse large B-cell lymphoma in S\u00e3o Paulo","volume":"69","author":"Xavier FD","year":"2014","unstructured":"Xavier FD, Levy D, Pereira J. Time-to-treatment of diffuse large B-cell lymphoma in S\u00e3o Paulo. Clinics (Sao Paulo). 2014, 69:367-71. 10.6061\/clinics\/2014(05)12","journal-title":"Clinics (Sao Paulo)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13150","article-title":"Predictors of delay in diagnosis and treatment in diffuse large B-cell lymphoma and impact on survival","volume":"168","author":"Nikonova A","year":"2015","unstructured":"Nikonova A, Guirguis HR, Buckstein R, Cheung MC. Predictors of delay in diagnosis and treatment in diffuse large B-cell lymphoma and impact on survival. Br J Haematol. 2015, 168:492-500. 10.1111\/bjh.13150","journal-title":"Br J Haematol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.5501\/wjv.v10.i3.97","article-title":"Impact of COVID-19 in patients with lymphoid malignancies","volume":"10","author":"Riches JC","year":"2021","unstructured":"Riches JC. Impact of COVID-19 in patients with lymphoid malignancies. World J Virol. 2021, 10:97-110. 10.5501\/wjv.v10.i3.97","journal-title":"World J Virol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13926","article-title":"Global reported impacts of COVID-19 on lymphoma patients and the emerging clinical management approaches in response to the ongoing pandemic","volume":"110","author":"Elliott EK","year":"2023","unstructured":"Elliott EK, Hensen R, Haupt LM, Griffiths LR. Global reported impacts of COVID-19 on lymphoma patients and the emerging clinical management approaches in response to the ongoing pandemic. Eur J Haematol. 2023, 110:457-69. 10.1111\/ejh.13926","journal-title":"Eur J Haematol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.5501\/wjv.v10.i6.312","article-title":"COVID-19 (SARS-CoV-2 infection) in lymphoma patients: a review","volume":"10","author":"Bonuomo V","year":"2021","unstructured":"Bonuomo V, Ferrarini I, Dell'Eva M, Sbis\u00e0 E, Krampera M, Visco C. COVID-19 (SARS-CoV-2 infection) in lymphoma patients: a review. World J Virol. 2021, 10:312-25. 10.5501\/wjv.v10.i6.312","journal-title":"World J Virol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000529","article-title":"EHA\/ESMO clinical practice guidelines for the management of malignant lymphoma: recommendations for the second phase of the COVID-19 pandemic","volume":"5","author":"Dreyling M","year":"2021","unstructured":"Dreyling M, Aurer I, Federico M, et al.. EHA\/ESMO clinical practice guidelines for the management of malignant lymphoma: recommendations for the second phase of the COVID-19 pandemic. Hemasphere. 2021, 5:e529. 10.1097\/HS9.0000000000000529","journal-title":"Hemasphere"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000538","article-title":"Risk factors and mortality of COVID-19 in patients with lymphoma: a multicenter study","volume":"5","author":"Regalado-Artamendi I","year":"2021","unstructured":"Regalado-Artamendi I, Jim\u00e9nez-Ubieto A, Hern\u00e1ndez-Rivas J\u00c1, et al.. Risk factors and mortality of COVID-19 in patients with lymphoma: a multicenter study. Hemasphere. 2021, 5:e538. 10.1097\/HS9.0000000000000538","journal-title":"Hemasphere"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005691","article-title":"A prognostic model for patients with lymphoma and COVID-19: a\u00a0multicentre cohort study","volume":"6","author":"Visco C","year":"2022","unstructured":"Visco C, Marcheselli L, Mina R, et al.. A prognostic model for patients with lymphoma and COVID-19: a\u00a0multicentre cohort study. Blood Adv. 2022, 6:327-38. 10.1182\/bloodadvances.2021005691","journal-title":"Blood Adv"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82615-4","article-title":"Importance of diagnosis-to-treatment interval in newly diagnosed patients with diffuse large B-cell lymphoma","volume":"11","author":"Yoshida M","year":"2021","unstructured":"Yoshida M, Nakaya Y, Shimizu K, et al.. Importance of diagnosis-to-treatment interval in newly diagnosed patients with diffuse large B-cell lymphoma. Sci Rep. 2021, 11:2837. 10.1038\/s41598-021-82615-4","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/493862-advanced-and-more-symptomatic-b-cell-non-hodgkin-lymphoma-at-diagnosis-after-covid-19-disruptions-in-a-romanian-tertiary-center","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T18:10:15Z","timestamp":1779387015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/493862-advanced-and-more-symptomatic-b-cell-non-hodgkin-lymphoma-at-diagnosis-after-covid-19-disruptions-in-a-romanian-tertiary-center"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.109376","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,21]]}}}